Which of the following is true regarding the labeling of controlled substances in Delaware?

In Delaware, the labeling of controlled substances is subject to specific regulations to ensure proper identification and safe use. The requirement for the label to include the patient's name and usage instructions serves multiple purposes: it ensures that the medication is dispensed to the correct individual and provides important information on how to use the medication safely and effectively. This crucial information helps in promoting patient adherence and preventing misuse or errors in medication administration.

Labeling laws in Delaware, as in many jurisdictions, are designed to safeguard public health and ensure that patients are fully informed of their treatment. Thus, having the patient's name and usage instructions on the label is not just a regulatory requirement, but also a best practice in pharmacy to enhance patient safety and facilitate effective communication between healthcare providers and patients.